Oral paricalcitol (19-nor-1,25- Dihydroxyvitamin D2) in women receiving chemotherapy for metastatic breast cancer:A feasibility trial

Julia A. Lawrence, Steven A. Akman, Susan A. Melin, L. Douglas Case, Gary G. Schwartz

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Oral paricalcitol (19-nor-1,25- Dihydroxyvitamin D2) in women receiving chemotherapy for metastatic breast cancer:A feasibility trial'. Together they form a unique fingerprint.

Medicine & Life Sciences